Drug description: flat round tablets of white or almost white color with flat edge and breaking line.
Indications and usage:
-Treatment and prevention (as part of complex therapy) of ARVI, influenza virus infection, herpetic eruptions of the skin and the mucous coat;
– Treatment and prevention (as part of complex therapy) of ARVI and influenza virus infection complications;
– As part of complex therapy of postprimary immunodeficiency states that occur as a result of frequent (anticipate) ARVI diseases, influenza virus infections, herpetic infections.
Contraindications: hypersensitivity to drug constituents; not for pediatric use under 6 months (because of insufficient medical data).
Dosage and administration:
1 tablet per administration 30 minutes before or after meals. Tablet should be kept under the tongue till complete dissolution (not swallowing and not chewing).
If Anaferon is prescribed for pediatric use (6 months-3 years) it is recommended to dissolve the tablet in a small amount (1 tablespoon) of boiled water of indoor temperature.
The treatment should begin at the earliest possible time – if the symptoms of AVI occur, according to the following treatment regimen: during the first 2 hours Anaferon is administrated every 30 minutes independently of the meals; then, during the first 24 hours Anaferon is administrated 3 times at regular intervals. Starting from the next 24 hours and further Anaferon is administrated 1 tablet 3 times a day till full recovery.
If there are no improvements on the third day of treatment it is advisable to consult a doctor.
In order to prevent the above mentioned diseases, Anaferon is administrated 1 tablet once a day for 3 months (during the epidemiological time).
Adverse effects: if the drug is administrated in accordance with prescribed dosage there are no possible adverse effects. Allergic reactions are possible.